Stocks rise broadly; Pfizer gains after FDA approves vaccine
Stocks notched gains on Wall Street on Monday, pushing the Nasdaq composite to an all-time high and helping the S&P 500 more than make up for its losses last week.
The S&P 500 rose 0.9%, after spending much of the day within striking distance of notching its own record high. The benchmark index ended less than 0.2% below its alltime high set a week ago.
The S&P 500 rose 37.86 points to 4,479.53. The Dow Jones Industrial Average added 215.63 points, or 0.6%, to 35,335.71. The Nasdaq gained 227.99 points, or 1.5%, to 14,942.65, eclipsing its last all-time high set early this month.
Small-company stocks outgained the broader market. The Russell 2000 index picked up 40.70 points, or 1.9%, to 14,942.65.
Pfizer rose 2.5% after the Food & Drug Administration gave full approval to its COVID-19 vaccine.